1. 39 NR2F6 (EAR-2) IS A NOVEL LEUKEMIA AND MDS ONCOGENE, OVER-EXPRESSED IN PATIENTS, THAT INHIBITS HEMATOPOIETIC DIFFERENTIATION AND BLOCKS ERYTHROPOIETIC DIFFERENTIATION AT THE PROERYTHROCYTE STAGE. (April 2015) Authors: Ichim, C.; Dervovic, D.; Koos, D.; Ichim, T.; Wells, R. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Infusion of ex‐vivo expanded human TCR‐αβ+ double‐negative regulatory T cells delays onset of xenogeneic graft‐versus‐host disease. (31st July 2018) Authors: Achita, P.; Dervovic, D.; Ly, D.; Lee, J. B.; Haug, T.; Joe, B.; Hirano, N.; Zhang, L. Journal: Clinical and experimental immunology Issue: Volume 193:Number 3(2018:Sep.) Page Start: 386 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗